ATE237308T1 - Unpolarer spray oder kapsel zur bukkalen anwendung - Google Patents

Unpolarer spray oder kapsel zur bukkalen anwendung

Info

Publication number
ATE237308T1
ATE237308T1 AT97914780T AT97914780T ATE237308T1 AT E237308 T1 ATE237308 T1 AT E237308T1 AT 97914780 T AT97914780 T AT 97914780T AT 97914780 T AT97914780 T AT 97914780T AT E237308 T1 ATE237308 T1 AT E237308T1
Authority
AT
Austria
Prior art keywords
percent
capsule
active compound
buccal use
buccal
Prior art date
Application number
AT97914780T
Other languages
English (en)
Inventor
Harry A Dugger Iii
Original Assignee
Novadel Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novadel Pharma Inc filed Critical Novadel Pharma Inc
Application granted granted Critical
Publication of ATE237308T1 publication Critical patent/ATE237308T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Anesthesiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
AT97914780T 1996-04-12 1997-02-21 Unpolarer spray oder kapsel zur bukkalen anwendung ATE237308T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/631,175 US5955098A (en) 1996-04-12 1996-04-12 Buccal non polar spray or capsule
PCT/US1997/002795 WO1997038663A2 (en) 1996-04-12 1997-02-21 Buccal, non-polar spray or capsule

Publications (1)

Publication Number Publication Date
ATE237308T1 true ATE237308T1 (de) 2003-05-15

Family

ID=24530090

Family Applications (2)

Application Number Title Priority Date Filing Date
AT97914780T ATE237308T1 (de) 1996-04-12 1997-02-21 Unpolarer spray oder kapsel zur bukkalen anwendung
AT02016165T ATE359761T1 (de) 1996-04-12 1997-02-21 Unpolarer spray zur bukkalen anwendung die alkaloidderivate oder analgetika enthält

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT02016165T ATE359761T1 (de) 1996-04-12 1997-02-21 Unpolarer spray zur bukkalen anwendung die alkaloidderivate oder analgetika enthält

Country Status (10)

Country Link
US (1) US5955098A (de)
EP (2) EP0904055B1 (de)
AT (2) ATE237308T1 (de)
AU (1) AU2190797A (de)
CA (1) CA2252050C (de)
DE (2) DE69720988T2 (de)
DK (1) DK0904055T3 (de)
ES (2) ES2286180T3 (de)
PT (1) PT904055E (de)
WO (1) WO1997038663A2 (de)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9523833D0 (en) * 1995-11-22 1996-01-24 Boots Co Plc Medical treatment
DE19646392A1 (de) 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
WO1998052540A1 (en) * 1997-05-22 1998-11-26 The Boots Company Plc Pharmaceutical compositions
US20040136915A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing atropine
US20030077229A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs
US20030095925A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
EP1036561A1 (de) * 1997-10-01 2000-09-20 Flemington Pharmaceutical Corporation Nichtpolare Spray zur bukkalen Anwendung
US7632517B2 (en) * 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
US20040141923A1 (en) * 1997-10-01 2004-07-22 Dugger Harry A. Buccal, polar and non-polar spray containing alprazolam
US20050163719A1 (en) * 1997-10-01 2005-07-28 Dugger Harry A.Iii Buccal, polar and non-polar spray containing diazepam
US20090162300A1 (en) * 1997-10-01 2009-06-25 Dugger Iii Harry A Buccal, polar and non-polar spray containing alprazolam
US20030077227A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US20050002867A1 (en) * 1997-10-01 2005-01-06 Novadel Pharma Inc. Buccal, polar and non-polar sprays containing propofol
US20030185761A1 (en) * 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
US20040136914A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing ondansetron
US20030095926A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
US20050180923A1 (en) * 1997-10-01 2005-08-18 Dugger Harry A.Iii Buccal, polar and non-polar spray containing testosterone
US20050281752A1 (en) * 1997-10-01 2005-12-22 Dugger Harry A Iii Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US20030095927A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders
US20050287075A1 (en) * 1997-10-01 2005-12-29 Dugger Harry A Iii Buccal, polar and non-polar spray or capsule containing drugs for treating pain
US20030077228A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating endocrine disorders
US20030190286A1 (en) * 1997-10-01 2003-10-09 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating allergies or asthma
US20040136913A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing sumatriptan
US20030082107A1 (en) * 1997-10-01 2003-05-01 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer
US6344222B1 (en) 1998-09-03 2002-02-05 Jsr Llc Medicated chewing gum delivery system for nicotine
US6358060B2 (en) 1998-09-03 2002-03-19 Jsr Llc Two-stage transmucosal medicine delivery system for symptom relief
AU6331299A (en) * 1998-10-02 2000-04-26 Jenapharm Gmbh & Co. Kg Use of testosterone esters and/or testosterone for producing bucally applicable bio-adhesive systems with time-released active ingredients
US6977083B1 (en) 1998-10-02 2005-12-20 Jenapharm Gmbh & Co. Kg Bioadhesive tablet containing testosterone/testosterone ester mixtures and method for producing a predetermined testosterone time-release profile with same
US6846495B2 (en) 1999-01-11 2005-01-25 The Procter & Gamble Company Compositions having improved delivery of actives
DE60040214D1 (de) * 1999-02-26 2008-10-23 Shionogi & Co Kaubare weichkapseln mit verbesserten verabreichungseigenschaften sowie verfahren zu deren herstellung
WO2000074652A1 (de) * 1999-06-02 2000-12-14 Hexal Ag Pharmazeutische zusammensetzung zur nasalen anwendung von wasserlöslichen wirkstoffen
SE0102197D0 (sv) * 2001-06-20 2001-06-20 Pharmacia Ab New product and use and manufacture thereof
SE521512C2 (sv) * 2001-06-25 2003-11-11 Niconovum Ab Anordning för administrering av en substans till främre delen av en individs munhåla
US6585997B2 (en) 2001-08-16 2003-07-01 Access Pharmaceuticals, Inc. Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
US20060073174A1 (en) * 2001-08-16 2006-04-06 Access Pharmaceuticals, Inc. Adherent and erodible film to treat a moist surface of a body tissue
US7138133B2 (en) 2001-10-10 2006-11-21 The Procter & Gamble Company Orally administered liquid compositions
SE0104388D0 (sv) * 2001-12-27 2001-12-27 Pharmacia Ab New formulation and use and manufacture thereof
US20030159702A1 (en) * 2002-01-21 2003-08-28 Lindell Katarina E.A. Formulation and use manufacture thereof
CN102600104B (zh) 2002-04-25 2015-06-24 旗帜药物胶囊公司 可咀嚼的软胶囊
US7767698B2 (en) * 2002-06-03 2010-08-03 Mcneil Ab Formulation and use thereof
US7085790B2 (en) 2002-12-06 2006-08-01 Sun Microsystems, Inc. Advancing cars in trains managed by a collector based on the train algorithm
US7069280B2 (en) 2002-12-06 2006-06-27 Sun Microsystems, Inc. Collection-tick mechanism for a collector based on the train algorithm
US7031990B2 (en) 2002-12-06 2006-04-18 Sun Microsystems, Inc. Combining external and intragenerational reference-processing in a garbage collector based on the train algorithm
ATE359075T1 (de) 2002-12-20 2007-05-15 Niconovum Ab Chemisch und physikalisch stabiles teilchenförmiges material enthaltend nikotin und microcrystalline cellulose
US20080213363A1 (en) * 2003-01-23 2008-09-04 Singh Nikhilesh N Methods and compositions for delivering 5-HT3 antagonists across the oral mucosa
US7062519B2 (en) 2003-02-27 2006-06-13 Sun Microsystems, Inc. Incremental scanning of enormous objects to improve scheduling and pause-time behavior of garbage collection
KR20140104986A (ko) * 2004-02-17 2014-08-29 트랜스셉트 파마슈티칼스, 인코포레이티드 구강 점막을 가로지르는 수면제 전달용 조성물 및 이의 사용 방법
WO2006004646A1 (en) * 2004-06-28 2006-01-12 Nektar Therapeutics Aerosol formulation comprising nicotine salt
US7620943B1 (en) 2004-06-30 2009-11-17 Sun Microsystems, Inc. Using class properties to segregate objects in a generation managed by the train algorithm
US7676801B1 (en) 2004-08-31 2010-03-09 Sun Microsystems, Inc. Scanning of evacuated objects in a generation managed by the train algorithm
JP5577021B2 (ja) 2005-02-17 2014-08-20 アボット・ラボラトリーズ 動物における障害を治療および予防するための薬剤組成物の経粘膜投与
AU2012200031B9 (en) * 2005-02-17 2014-03-27 Zoetis Belgium S.A. Transmucosal administration of drug compositions for treating and preventing disorders in animals
WO2006100075A2 (en) * 2005-03-22 2006-09-28 Niconovum Ab Use of an artificial sweetener to enhance absorption of nicotine
US20070287740A1 (en) * 2005-05-25 2007-12-13 Transcept Pharmaceuticals, Inc. Compositions and methods of treating middle-of-the night insomnia
NZ563979A (en) * 2005-05-25 2011-02-25 Transcept Pharmaceuticals Inc Solid compositions and methods for treating middle-of-the night insomnia
US20070225322A1 (en) * 2005-05-25 2007-09-27 Transoral Pharmaceuticals, Inc. Compositions and methods for treating middle-of-the night insomnia
JP5694645B2 (ja) 2006-03-16 2015-04-01 ニコノヴァム エービーＮｉｃｏｎｏｖｕｍ Ａｂ 改善された嗅ぎたばこ組成物
CA2649895C (en) * 2006-04-19 2013-03-26 Novadel Pharma Inc. Stable hydroalcoholic oral spray formulations and methods
US8642016B2 (en) 2006-07-21 2014-02-04 Jsrnti, Llc Medicinal delivery system, and related methods
KR20090055606A (ko) * 2006-09-27 2009-06-02 니코노범 에이비 지향성 용도
CA2673049C (en) * 2006-12-22 2016-02-23 Novadel Pharma Inc. Stable anti-nausea oral spray formulations and methods
EP2112923A1 (de) 2007-01-22 2009-11-04 Targacept Inc. Intranasale, orale und sublinguale verabreichung von metanikotin-analogen
WO2008141264A1 (en) * 2007-05-10 2008-11-20 Novadel Pharma Inc. Anti-insomnia compositions and methods
US20100008868A1 (en) * 2007-11-27 2010-01-14 Harry Dugger Sustained remission of atopic dermatitis
GB2469792A (en) * 2009-04-23 2010-11-03 Calvin John Ross Oil-based pharmaceutical formulation for sublingual delivery
CN102458358A (zh) * 2009-04-23 2012-05-16 伦敦制药有限公司 包含中性油的舌下药学组合物
JP5892940B2 (ja) 2009-11-25 2016-03-23 アリスジェン ソシエテ アノニム クラウン化合物及び／又は対イオンと複合体化されたペプチドを含む粘膜送達組成物
GB2482868A (en) * 2010-08-16 2012-02-22 Franciscus Wilhelmus Henricus Maria Merkus A testosterone liquid spray formulation for oromucosal administration
EP2526971A1 (de) 2011-05-25 2012-11-28 ArisGen SA Mukosale Freisetzung von Arzneimitteln
GB201200062D0 (en) 2012-01-04 2012-02-15 Innotesto Bvba Estradiol oromucosal liquid compositions
US20220312826A1 (en) * 2021-04-06 2022-10-06 Altria Client Services Llc Liquid mixtures of triglyceride and liquid nicotine
USD1081739S1 (en) 2021-04-06 2025-07-01 Altria Client Services Llc Die for gum forming
US12295412B2 (en) 2022-01-28 2025-05-13 Altria Client Services Llc Oral pouch product

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2750090A1 (de) * 1976-11-19 1978-06-01 Sandoz Ag Neue verabreichungsformen fuer organische verbindungen
DE3338978A1 (de) * 1982-10-29 1984-05-03 Basf Ag, 6700 Ludwigshafen Verapamil und gallopamil und ihre physiologisch vertraeglichen salze zur resorptiven anwendung auf den schleimhaeuten des mundes, des nasen-rachen-raums und des rektums
DE3246081A1 (de) * 1982-12-13 1984-06-14 G. Pohl-Boskamp GmbH & Co Chemisch-pharmazeutische Fabrik, 2214 Hohenlockstedt Nitroglycerin-spray
US4935243A (en) * 1988-12-19 1990-06-19 Pharmacaps, Inc. Chewable, edible soft gelatin capsule
JP3219096B2 (ja) * 1990-05-10 2001-10-15 ニコメド ファーマ エイエス ｎ―グリコフロール類及びｎ―エチレングリコール類を含有する医薬製剤
US5474759A (en) * 1991-06-10 1995-12-12 Schering Corporation Non-chlorofluorocarbon aerosol formulations
GB9118830D0 (en) * 1991-09-03 1991-10-16 Minnesota Mining & Mfg Medical aerosol formulations
DE4230876A1 (de) * 1992-03-17 1993-09-23 Asta Medica Ag Druckgaspackungen unter verwendung von polyoxyethylen-glyceryl-oleaten
US5502076A (en) * 1994-03-08 1996-03-26 Hoffmann-La Roche Inc. Dispersing agents for use with hydrofluoroalkane propellants
GB9405304D0 (en) * 1994-03-16 1994-04-27 Scherer Ltd R P Delivery systems for hydrophobic drugs
US5589156A (en) * 1994-05-02 1996-12-31 Henry; Richard A. Prilocaine and hydrofluourocarbon aerosol preparations
WO1995031182A1 (en) * 1994-05-13 1995-11-23 Aradigm Corporation Narcotic containing aerosol formulation
US5635161A (en) * 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils

Also Published As

Publication number Publication date
DE69737637T2 (de) 2008-01-10
EP0904055B1 (de) 2003-04-16
DK0904055T3 (da) 2003-08-18
PT904055E (pt) 2003-08-29
CA2252050A1 (en) 1997-10-23
DE69720988D1 (de) 2003-05-22
ATE359761T1 (de) 2007-05-15
ES2200165T3 (es) 2004-03-01
WO1997038663A3 (en) 1998-02-05
CA2252050C (en) 2005-12-27
EP0904055A2 (de) 1999-03-31
DE69737637D1 (de) 2007-05-31
US5955098A (en) 1999-09-21
EP1275374A1 (de) 2003-01-15
ES2286180T3 (es) 2007-12-01
AU2190797A (en) 1997-11-07
DE69720988T2 (de) 2003-12-11
WO1997038663A2 (en) 1997-10-23
EP1275374B1 (de) 2007-04-18

Similar Documents

Publication Publication Date Title
ATE237308T1 (de) Unpolarer spray oder kapsel zur bukkalen anwendung
EP1952802A3 (de) Oraler, polarer und nicht-polarer Spray bzw. Kapsel
CA2058428A1 (en) Analgesic formulations
EP0663401A4 (de) Morphinan-derivate und ihre medizinische verwendung.
GB2220949B (en) Aerosol composition comprising nitroglycerin as active ingredient
CA2059263A1 (en) Composition comprising the (-) enantiomer of cis-4-amino-1-(2-hydromethyl-1,3-oxathiolan-5-yl)-(1h)-pyrimidine-2-one or an enriched composition thereof, and its uses as a pharmaceutical agent
WO1996040086A3 (en) Compositions and methods for topical administration of pharmaceutically active agents
WO2000016762A3 (en) Method for reducing nicotine dependency
NZ504076A (en) A topical formulation which induces a minimal systemic effect when applied to the skin, the topical formulation comprising an immunosuppressive macrolide selected from sirolimus, FK506 and SDZ ASM 981 and a permeation modulator for the treatment of a dermatological condition
ZA9811796B (en) New tetracyclic analogues of camptothecins, their preparation processes, their use as medicaments and the pharmaceutical compositions containing them.
EP1466606A3 (de) Verwendung von Inosine zur Herstellung eines Medikamentes zur Stimulierung des Axonwachstums von ZNS-Neuronen
CA2339765A1 (en) Compounds and compositions for delivering active agents
WO1999007351A3 (en) Indole derivatives and their use as mcp-1 antagonists
CA2104474A1 (en) Compositions and methods for topical administration of pharmaceutically active agents
IL135258A0 (en) Bioadhesive compositions and methods for topical administration of active agents
CA2275889A1 (en) Formulation and method for treating neoplasms by inhalation
EP1574219A3 (de) Verfahren zur Hemmung der Fibrose mittels eines Somatostatin-Agonisten
CA2301017A1 (en) Use of propyl gallate to increase bioavailability of orally administered pharmaceutical compounds
CA2261923A1 (en) Pyridazino [4,5-b]-quinoline 5-oxide derivatives, their preparation and their use as glycine antagonists
NO992944D0 (no) Virkestoffbµrer for avgivelse av apomorfin i munnhulen
AU5326498A (en) Prodrug forms and new analogues of camptothecin, their use as medicaments
CA2284774A1 (en) Theobromine antitussive compositions
GR1002907B (el) Επικαλυμμενο δισκιο μηλεινικης τριμεβουτινης
IE894049L (en) Therapeutically active substituted benzimidazole and process¹for its preparation
PT975348E (pt) Composicoes de tibolona estabilizadas

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0904055

Country of ref document: EP